Laboratory tests in patients with AHA typically show a prolonged activated partial thromboplastin time (aPTT), with a normal prothrombin time, along with reduced FVIII activity and the presence of autoantibodies (3), (8). The gene discussed is F8; the disease is autoimmune hemolytic anemia.